Bronchiectasis with Acute Exacerbation
Learn about bronchiectasis with acute exacerbation diagnosis, including clinical documentation tips, medical coding (ICD-10, SNOMED CT), and managing acute exacerbations of bronchiectasis. Find information on bronchiectasis flare symptoms, treatment, and best practices for healthcare professionals. Improve your understanding of this respiratory condition and ensure accurate documentation and coding for bronchiectasis with acute exacerbation.
Permanent widening of airways, often with recurrent infections leading to cough, mucus, and shortness of breath.
Increased cough, change in sputum, shortness of breath, fatigue, fever, wheezing, chest pain.
Outpatient clinic, urgent care, hospital (for severe exacerbations).
ICD-10 Code Families
Complete code families applicable to J47.1
When to use each related code
| Description | When to use |
|---|---|
| Bronchiectasis with acute infection flare-up. | Document when bronchiectasis patient presents with increased cough, sputum production, and shortness of breath. |
| Chronic bronchiectasis without active infection. | Use for patients with persistent cough and sputum production due to bronchiectasis, but no signs of acute exacerbation. |
| Simple chronic bronchitis, not bronchiectasis. | Chronic productive cough without underlying bronchiectasis or other specific cause. Consider COPD if FEV1/FVC < 0.7. |
Best-practice checklist
- ✓Document sputum characteristics (color, volume, purulence)
- ✓Record FEV1/FVC ratio pre/post-bronchodilator
- ✓Detail antibiotic treatment plan (drug, dose, duration)
- ✓Specify imaging findings confirming bronchiectasis exacerbation
- ✓Note symptoms and signs like cough, dyspnea, and chest pain
Common pitfalls to avoid
Coding acute exacerbation without specifying underlying bronchiectasis severity or infection leads to undercoding and lost revenue.
COPD or asthma with similar symptoms may be misdiagnosed as bronchiectasis, impacting quality metrics and reimbursement.
Failing to code the specific infectious agent causing the exacerbation leads to inaccurate severity reflection and DRG assignment.
Best-practice tips
- 01Document sputum changes (color, volume) for accurate ICD-10 coding (J47).
- 02Ensure CDI capture of antibiotic use, oxygen therapy, and hospitalizations.
- 03Code acute lower respiratory infection (J22) if present with bronchiectasis.
- 04For compliance, document patient education on airway clearance techniques.
- 05Monitor lung function via spirometry for severity assessment and coding.
Step-by-step checklist
- 1
Confirm 3+ months purulent sputum production (ICD-10 J47)
- 2
Document acute worsening: increased cough, dyspnea, sputum volume/purulence
- 3
Assess for signs of infection: fever, elevated WBC, new infiltrate on CXR
- 4
Rule out other respiratory conditions: pneumonia, COPD, TB (differential diagnosis)
- 5
Optimize antibiotic therapy based on sputum culture & guidelines (patient safety)
Ready-to-paste narrative
Patient presents with an acute exacerbation of bronchiectasis, manifested by increased sputum production, change in sputum color (yellow, green, or blood-tinged), worsening cough, increased dyspnea, and pleuritic chest pain. The patient reports a history of bronchiectasis, confirmed by previous high-resolution computed tomography (HRCT) scan of the chest. Pulmonary function tests (PFTs) may demonstrate obstructive or mixed obstructive-restrictive pattern. On physical examination, crackles, rhonchi, and wheezing may be auscultated. The exacerbation is likely triggered by a respiratory tract infection, potentially bacterial, as evidenced by the change in sputum characteristics. Differential diagnoses include pneumonia, chronic obstructive pulmonary disease (COPD) exacerbation, and asthma. Treatment plan includes antibiotics targeted towards common respiratory pathogens, airway clearance techniques such as chest physiotherapy and postural drainage, bronchodilators via nebulizer or inhaler, and systemic corticosteroids to reduce airway inflammation. Patient education regarding pulmonary hygiene, medication adherence, and early recognition of exacerbation symptoms is provided. Follow-up scheduled to assess treatment response and adjust management as needed. ICD-10 code J47.0, Bronchiectasis with acute lower respiratory infection, is appropriate for this encounter.
Common questions and answers
What are the best evidence-based treatment strategies for managing an acute exacerbation of bronchiectasis in adults?+
Managing an acute exacerbation of bronchiectasis in adults requires a multi-faceted approach based on current guidelines and patient-specific factors. Key strategies include optimizing airway clearance techniques (e.g., positive expiratory pressure devices, high-frequency chest wall oscillation), initiating or adjusting antibiotic therapy based on sputum culture and sensitivity where possible (consider empiric coverage for common pathogens like Pseudomonas aeruginosa, Haemophilus influenzae, and Streptococcus pneumoniae), and controlling inflammation with systemic corticosteroids (prednisone or equivalent). In more severe exacerbations, hospitalization and supplemental oxygen therapy may be necessary. Consider implementing pulmonary rehabilitation following the acute phase to improve long-term lung function and quality of life. Explore how the latest clinical trials inform antibiotic stewardship in bronchiectasis management to enhance treatment efficacy and minimize antibiotic resistance.
How can I differentiate between a bronchiectasis flare and other respiratory conditions like pneumonia or COPD exacerbation in a clinical setting?+
Differentiating a bronchiectasis flare from other respiratory conditions like pneumonia or COPD exacerbation can be challenging due to overlapping symptoms. A thorough clinical assessment is crucial. Focus on the patient's history of bronchiectasis, including characteristic symptoms like chronic cough with copious mucopurulent sputum production. Physical exam findings such as crackles, wheezing, and clubbing can be suggestive, but not definitive. Imaging studies, particularly high-resolution computed tomography (HRCT) scans, play a vital role in confirming bronchiectasis and assessing the extent of disease. Sputum culture can help identify the causative pathogen and guide antibiotic therapy, particularly if Pseudomonas aeruginosa is suspected. While pulmonary function tests (PFTs) can reveal obstructive or restrictive patterns, they are less specific for diagnosing an acute exacerbation. Learn more about utilizing point-of-care diagnostics like procalcitonin to aid in distinguishing bacterial from viral infections and optimizing antibiotic use.
What are the long-term complications and prognosis for patients with recurrent acute exacerbations of bronchiectasis?+
Recurrent acute exacerbations of bronchiectasis can lead to progressive lung damage and a decline in respiratory function. Common long-term complications include respiratory failure, pulmonary hypertension, hemoptysis, and cor pulmonale. Furthermore, repeated exacerbations can negatively impact a patient's quality of life, increasing fatigue, dyspnea, and anxiety. The prognosis for patients with recurrent exacerbations varies depending on the underlying cause of bronchiectasis, disease severity, and the effectiveness of management strategies. Optimizing long-term management through strategies like airway clearance techniques, inhaled medications, and pulmonary rehabilitation can help reduce the frequency and severity of exacerbations, slowing disease progression and improving patient outcomes. Consider implementing a personalized management plan that addresses both the underlying disease and the patient's individual needs and comorbidities. Explore how emerging therapies targeting specific inflammatory pathways may offer new hope for patients with severe bronchiectasis and frequent exacerbations.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.